Read here for macro headwinds impacting Twist Bioscience's growth and NGS business. Learn about TWST's path to profitability ...

Adeno-associated virus serotype 9 (AAV9) is currently considered the benchmark vector for clinical cardiac gene transfer applications but can entail severe hepatotoxicity because of its strong ...

According to Sanofi, SAR446597 delivers genetic material encoding two therapeutic antibody fragments that target and inhibit two components of the complement pathway, namely C1s in the classical ...